What do nitrogen explosives and dog food have in common?
Adam Hall left the explosives industry to run EBOS, one of Australia and New Zealand's largest healthcare distributors, with A$13.5b annual revenue across medicines, a pharmacy network, and pet brands like Black Hawk and VitaPet.
Adam explains his expectations for GLP-1 growth, how the COVID pet boom is shaping demand, and why he believes in-store care is the future of pharmacy.
Hear why Adam says the company’s profit line doesn’t tell the full story, and how he’s approaching the deals EBOS wants to do next.
For more places to follow Shared Lunch—check out http://linktr.ee/sharedlunch
Shared Lunch is brought to you by Sharesies Australia Limited (ABN 94 648 811 830; AFSL 529893) in Australia and Sharesies Limited (NZ) in New Zealand. It is not financial advice. Information provided is general only and current at the time it’s provided, and does not take into account your objectives, financial situation and needs. We do not provide recommendations and you should always read the disclosure documents available from the product issuer before making a financial decision. Our disclosure documents and terms and conditions—including a Target Market Determination and IDPS Guide for Sharesies Australian customers—can be found on our relevant Australian or NZ website.
Investing involves risk. You might lose the money you start with. If you require financial advice, you should consider speaking with a qualified financial advisor. Past performance is not a guarantee of future performance.

Yields hit 19-year high, RBA hike predicted | Market Movements
04:40

Lodestone Energy's IPO, explained
26:24

“It’s gonna be uncomfortable” — Australia braces for an RBA rate rise
04:14